- Big Pharma Doubles Down on CRISPR for New Drugs
A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body.
Can the powerful gene-editing tool CRISPR help cure diseases? Drug companies are racing to find out.
Digest powered by RSS Digest